Clinical Trial Update: Xeloda Maintenance Versus BSC in Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

Clinical trial update for maintenance therapy with capecitabine (Xeloda) versus best supportive care in metastatic colorectal cancer. The Phase 3 trial is termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Xeloda (capecitabine)

Snippet

Sponsor: Samsung Medical Center | Conditions: Metastatic Colorectal Cancer | Phase 3 | Status: TERMINATED